BSEGeneral7 Oct 2026 · 7 Oct 2026, 06:44 pm
NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026
Beryl Drugs Ltd · 524606
✦ AI Summarycompliance
Beryl Drugs Ltd has filed a non-applicability certificate under Regulation 57(5) for the quarter ended 30.09.2026, stating that there are no non-convertible securities for which interest/dividend/principal is payable during the quarter.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beryl Drugs Ltd - 524606 - Compliance-57 (5) : intimation after the end of quarter
Attachments (1)
📄pdf
Download →
874faff7-5431-4c73-9c1a-0a22b1c7b299.pdf
View document text
BERYL.
orves tures
TR ee lg .d :. (O 0f 7f 3. 1: )2 9 2,
1N 7e 6e 7r
g Ear -,
a" iM la y
a bn ek
yW la dt re ur
sP 2a 5rk
yR ao ha od o" .,
oBi mc h |o l Ci
H Na p :s i L,
2I 4N 2D 3O MR PE 1- 94 95 32 P0 L1 C6
( 7M 8.P 4. 0) INDIA
Date: 06" October, 2026
The DCS- Listing,
The Bombay Stock Exchange Limited,
Phiroze JeeJeebhoy Towers,
Dalal Street, Mumbai — 400 001
Script Code: 524606
Sub.: Filing of Reports for the quarter ended on 30.09.2026
Dear Sir,
With reference to various conditions stipulated under the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 and other regulation required to be complied by
the listed Companies, we are enclosing herewith the following documents for your record,
relating to quarter ended on 30th September, 2026
1. Regulation 74 (5) - Certificate under Regulation 74(5) of the SEBI (Depositories and
Participants) Regulations, 2018 for the quarter ended 30" September, 2026
2. Regulation 57(5)- Non- Applicability Certificate Under Regulation 57(5) for the quarter
ended 30 September, 2026
For Beryl Drugs Limited_
Sudhir Sethi
Chairman& Di
DIN: 00090172
BERHL
DRUGS LIMITED
TR ee lg .d :. (O 0f 7f 3. 1: )2 9 2,
1N 7e 6e 7r 7N a
g Ear -,
a" iM la :y a bn ek
yW la dt re ur
sP 2a 5rk
yR ao ha od o" .,
oBi mc h |o l Ci
H Na p :s i L,
2I 4N 2D 3O MR PE 1- 94 95 32 P0 L1 C06
( 7M 8. 4P. 0) INDIA
Date: 06" October, 2026
The Compliance Department,
BSE Ltd,
Phiroze Jeejeebhoy Tower,
25" Floor, Dalal Street,
Mumbai - 400001
BSE CODE: 524606
Sub: Compliance under regulation 57(5) for the quarter ended 30.09.2026.
Dear Sir/Madam,
We wish to inform that Regulation 57(5) is not applicable to our company since there is no non
- convertible securities for which interest/dividend/principal is payable during the quarter
ended 30.09.2026.
You are requested to please take the same on record.
For Beryl Drugs Limited
DIN: 00090172